1Deinum J,Tarnow L,Van Gool JM,et al.Plasma reninand prorenin and rennin gene variation in patients with insulin dependent diabetes mellitus and nephropathy.Nephrol Dial Transplant,1999,14:1904-1911.
2Solini A,Vestra MD,Saller A,et al.The angiotenin converting enzyme DD gene typeis associated with glomerulopathy lesions in type 2 diatetes.Diabetes,2002,51:251-255.
3Iwasaki N,Babazono T,Tsuchiya K,et al.Prevalence of A to G mutation at nucleotide 3243 of the mitochondrial tRNA leu(UUR) gene in Japanese patients with diabetes mellitus and end stage renal disease.J Hum Genet,2001,46:330-334.
4Cooper ME,Mundel P,Boner G:Role of nephrin in renal disease including diabetic nephropathy.Semin Nephrol,2002,22:393-398.
5Gunter Wolf,Eberhard Ritz.Diabetic Nephropathy in Type 2 Diabetes Prevention and Patient Management.J Am Soc Nephrol,2003,14:1396-1405.
6Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet, 1998,352:837-853.
7Fioretto P,Steffes MW,Sutherland DE,Goetz FC,Mauer M:Reversal of lesions of diabetic nephropathy after pancreas transplantation.N Engl J Med,1998, 339:69-75.
9American Diabetes Association:Evidence-based nutrition principles and recommendations for the treatment and prevention ofdiabetes and related complications.Diab Care 2002,25(suppl 1):s50-s60.
10Heart Outcomes Prevention Evaluation study investigators.Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus.Lancet,2000,355:253-259.
